2 unknown, 1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Dai Huaping: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China Interstitial Lung Disease (ILD) | Recruiting | Dai Huaping | 10000 | 2021-12-01 | 2024-10-23 | |
| Idiopathic Pulmonary Fibrosis Registry China Study Idiopathic Pulmonary Fibrosis | Unknown | Dai Huaping | 800 | 2018-07-01 | 2018-09-11 | |
| Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis GM-CSF - Pulmonary Alveolar Proteinosis, Treatment | Phase 2 | Unknown | Dai Huaping | 60 | 2016-08-01 | 2017-10-20 |
Idiopathic Pulmonary Fibrosis (1) · Lung Diseases, Interstitial (1) · Pulmonary Alveolar Proteinosis (1)
Granulocyte-Macrophage Colony-Stimulating Factor (1)
China (3)